Male and female immune responses are known to differ resulting in an increased prevalence of autoimmunity in women. Here sex differences in T-cell subset frequency and function during adolescence were examined in healthy donors and patients with the autoimmune disease juvenile (J)SLE; onset of JSLE commonly occurs during puberty suggesting a strong hormonal influence. Healthy adolescent males had increased regulatory T-cell (Treg) frequency, and increased Treg suppressive capacity and IL-4 production compared to healthy adolescent females. The T-helper 2-like profile in male Tregs was associated with increased expression of GATA3 which correlated significantly with elevated Treg plasma membrane glycosphingolipid expression. Differential Treg phenotype was associated with unique serum metabolomic profiles in males compared to female adolescents. Notably, very low density lipoprotein (VLDL) metabolomic signatures correlated positively with activated Tregs in males but with resting Tregs in females. Consistently, only VLDL isolated from male serum was able to induce increased Treg IL-4 production and glycosphingolipid expression following in cultured cells.
INTRODUCTION
Males and females differ in their immune response to foreign and self-antigens and consequently they differ in their risk of infection and prevalence of autoimmune diseases; males are generally more susceptible to infections than females, and females represent ~80% of all patients with autoimmunity [1] . It is known that fundamental differences exist in the frequency and activity of T-cell subsets by gender across multiple ethnicities [2] [3] [4] .
Notably, some gender differences in adaptive immune responses are present throughout life, while others are manifested following the onset of puberty and prior to reproductive senescence implicating both genetic and hormonal influences [5] . Counter to the prevalence of autoimmunity in females, risk of developing cardiovascular disease and relative risk of hypercholesterolaemia is lower in pre-menopausal healthy females compared to males. This is largely due to reduced pro-atherogenic low density lipoproteins (LDL) and increased anti-atherogenic high density lipoproteins (HDL) in females. Following menopause, female LDL increases to a higher level to males, thus reducing their cardiovascular disease protection. HDL remains higher in females at all ages [10] [11] [12] . The interaction between serum lipids, sex hormones and immune cell phenotype in males and females remains largely unknown.
Systemic lupus erythematosus (SLE) is a complex autoimmune disorder characterized by loss of immune cell regulation and the presence of autoantibodies against multiple nuclear and non-nuclear antigens, resulting in chronic inflammation, multiple organ damage. Hormones have been implicated in the etiology of SLE due to the sexual dysmorphism observed in SLE where the female to male ratio is 9:1 [1] . Between 15 and 20% of all patients with SLE have juvenile-onset disease (JSLE) which is characterised by a more severe disease phenotype [6] [7] . Importantly, cardiovascular disease (CVD) is recognised as a serious long term complication for all patients with SLE [8] . Interplay between traditional cardiovascular risk factors (such as dyslipidemia) and risk factors associated with continuing SLE disease (including hormonal influences), are not understood.
Regulatory T cells (Tregs) have been implicated in SLE due to their suppressive capabilities in the immune system. In SLE, disproportionate Th17-to-Treg ratios have been reported in several studies resulting in a more pro-inflammatory phenotype [13] [14] [15] .
In health, Treg frequencies are shown to be lower in females following puberty suggesting a plausible reason for the gender bias of autoimmune disease [16] . No difference in Treg frequencies were reported in Australian infants from birth to one year of age [17] . Controversially it has been found that physiological levels of estrogen can induce the expansion of Treg cells [18] and Treg numbers are increased during the menstrual cycle when estrogen levels are highest before ovulation [19] . Foxp3 is a critical protein responsible for the development and function of Treg cells. The gene for Foxp3 is found on the X-chromosome [20] providing a link between sex and Treg development.
Understanding the relationship between sex and Tregs is important for investigation into the aetiology of autoimmune diseases such as SLE. Here the phenotype and function of Tregs in a young cohort of healthy post-pubertal males and females was assessed. Male Tregs had a higher frequency and increased suppressive capacity compared to females and this was associated with an increased expression of IL-4, GATA3, GLUT-1 (glucose transporter-1) and plasma membrane glycosphingolipids. Serum lipids, particularly very low density lipoproteins (VLDL), were associated with the differential Treg phenotype seen between healthy males and females. These sex differences in Tregs and serum 
RESULTS

Young adolescent healthy males have increased Treg frequency and suppressive capacity compared to females
The increased prevalence of autoimmunity in females has been associated with reduced Treg frequencies compared to males [21] . In healthy adolescent males, Treg (CD4 + CD25 + CD127 -, Supplementary Figure 1 for gating strategy) frequency and absolute number were significantly elevated and responder T cells (Tresp, CD4 + CD25 -CD127 + ) were significantly reduced compared to healthy female donors (matched for age, ethnicity and pubertal state) ( Figure 1A -D and Supplemental Table 1 for demographic information of healthy donors), confirming previous findings [1, 16] . No significant differences in the frequency of other CD4 + and CD8 + T-cell subsets were seen ( Figure 1A ).
In addition to increased number, Tregs from adolescent healthy males had a significantly greater capacity to suppress activated Tresps compared to female Tregs even at higher dilutions, suggesting increased Treg functionality in males ( Figure 1E Figure 4 ) between males and females. In support of increased IL-4 production by male Tregs, GATA-3 (the transcription factor associated with an IL-4/Th2 phenotype [22] ) was also significantly increased in healthy male compared to female Tregs whilst no difference was seen in T-bet expression ( Figure 1J ).
Tregs from adolescent males have a more metabolically active phenotype characterised by increased plasma membrane glycosphingolipids and Glut-1 expression that correlates with a Th2 phenotype
Further analysis of male and female Treg phenotype revealed a more metabolically activated profile in adolescent males characterised by increased GLUT-1 and lipid raft expression (assessed using cholera-toxin-B, CTB to measure plasma membrane glycosphingolipids (GSL) [23] ), although expression of activation markers CD69 and PD-1 remained unchanged (Figure 2A -C).
Our previous work shows that T-cell activation and polarisation is influenced by changes in the plasma membrane lipid profile ( Figure 2D [24, 25] ). The increase in GSL expression in male Tregs was matched by elevated UDP-Glucose Ceramide Glucosyltransferase (UGCG) gene expression, the rate limiting enzyme in the GSL synthesis pathway [26] (Figure 2E ). No differences were seen in Treg cholesterol expression ( Figure 2F ), or cholesterol biosynthesis (HMG-CoAR) and cholesterol efflux (ABCA1 and ABCG1) gene expression between males and females ( Figure 2G ). However, the GSL:cholesterol ratio was significantly elevated ( Figure 2H ) and the plasma membrane lipid order (measured by the phase sensitive probe ANE) ( Figure 2I) was reduced suggesting that the plasma membrane of male Tregs was more fluid (less ordered) compared to female Tregs. Finally, a significant positive correlation was observed between male Treg plasma membrane GSL levels and GLUT-1, CD69 and GATA-3 expression ( Figure 2J and K) implying that differences in Treg function between males and females may be related to a differential lipid metabolism.
Healthy adolescent males and females have unique serum metabolomic profiles associated with differential Treg phenotypes
The onset of puberty is known to alter lipid metabolism [27] [28] [29] [30] [31] and these differences could contribute to the changes in plasma membrane lipid profiles and function seen in male compared to female Tregs [32] . Following an in depth analysis of serum lipid metabolites using an established nuclear magnetic resonance (NMR) spectroscopy platform (https://nightingalehealth.com/) (Supplemental Table 2 ), 42 metabolites were significantly associated with adolescent post-pubertal males and 24 with females ( Figure   3A , Supplemental Table 3 ). Notably, a significant increase in VLDL particle subsets (including size and lipid composition) was identified in males, and a significant increase in HDL-particles was seen in females ( Figure 3A , Supplemental Table 3 ). This was supported by an increase in Apolipoprotein (Apo)-B in males and ApoA1 in females.
Furthermore, there was a significant increase in serum polyunsaturated fatty acids (PUFA's) in adolescent females and increased saturated fatty acids SFA's and serum triglycerides (TG) in adolescent males. Unbiased hierarchical clustering using the significantly altered metabolites between males and females was able to differentiate two clusters. Cluster-1 contained 79% of the males with VLDL measures as the predominant metabolites. Cluster-2 contained 76% of the females with HDL measures as the predominant metabolites ( Figure 3B ). Principle component analysis (PCA) was similarly effective in clustering males from females using the significantly altered metabolites between males and females ( Figure 3C ).
To investigate the hypothesis that sex hormones can influence lipid metabolism, we explored the serum lipid profile of males and females with gender dysphoria (GD).
Biological males (XY) with inhibited testosterone and supplemented estrogen had an increase in HDL metabolites including ApoA1 ( Figure 3D ) resembling the profile of young post-pubertal females. In contrast, biological females (XX) with estrogen inhibition and testosterone supplementation had decreased HDL, ApoA1 and the PUFA docosahexaenoic acid (DHA) and up to 4-fold increased VLDL expression ( Figure 3E) resembling the profile of young post-pubertal males. From the metabolites significantly altered between males and females, proportional Venn analysis identified 16 metabolites that overlap with the male GD analysis and 7 that overlap with the female GD analysis ( Figure 3F , Supplemental Table 4 ). A further 8 metabolites were common between male and female GD donors and 6 metabolites overlapped with all the analysis comparisons.
Thus supporting that hormones play a role in serum lipid metabolism.
When the sex specific metabolic signatures were correlated with male and female Treg frequency, no relationships were identified (Supplemental Figure 5A ). However, when functional Treg subsets were considered (determined using the gating strategy described by Miyara et.al [33] , Figure 3G ) differential correlations were detected. In males, VLDL correlated positively with activated Tregs (CD25 ++ CD45RA, proliferative and suppressive) and negatively with resting Tregs (CD25 + CD45RA + , non-proliferating and suppressive) ( Figure 3H ). In females, VLDL had a significant positive correlation with resting Tregs. A more detailed analysis of VLDL particles revealed that male small and medium sized VLDL contained significantly more triglycerides and free cholesterol whereas VLDL from females contained more cholesterol, cholesterol esters and phospholipids ( Figure 3I ). Figure   5B ). Thus, healthy adolescent males and females had Tregs with a differential membrane lipid and metabolic profile and significantly different serum lipid signatures that correlated with different Treg functional phenotypes.
No associations were identified between HDL and Treg phenotype (Supplemental
Differences in VLDL composition between males and females drive differences in
Treg phenotype in vitro
The results so far show that the composition of the VLDL particles in adolescent males and females (post puberty) are different. To test the functional impact of these differences in VLDL composition on Tregs, healthy human PBMC's from anonymised leukocyte cones were rested in serum free medium and then stimulated with VLDL isolated from healthy male and female serum samples ( Figure 4A for experimental plan).
Culture with male VLDL recapitulated the ex vivo male Treg phenotype, characterised by increased IL-4 production and increased GSL expression compared to PBMCs cultured with female VLDL (Fig 4B-D) . Conversely, female VLDL significantly increased Treg phospholipid expression compared to male VLDL ( Figure 4E ). No significant differences were detected for Treg cholesterol ( Figure 4F ), IL-10 or IFN-γ production as we described previously ( Figure 1H ). Thus, healthy Treg phenotype can be differentially altered by VLDL isolated from males or females.
Sex specific differences in metabolism and Treg phenotype are lost in JSLE
The reduced number and suppressive capacity of Tregs in adolescent females could play a role in the increased susceptibility of females to autoimmune diseases. Juvenileonset (J)SLE has a substantial female sex bias, with a 4.5:1 female:male ratio [34] . The T cell phenotype was examined in male and female patients with JSLE who were age matched to both each other and to the adolescent healthy controls (Supplemental Table   5 ). Strikingly, the sex-associated differences identified between Tregs from healthy donor males and females were lost in patients with JSLE; this was true for Treg frequency, lipid profile, and IL-4 production ( Figure 5A -D). Significant differences in T-cell phenotype, including Tregs, were identified in JSLE females when compared to healthy females but not for JSLE males when compared to healthy males (Supplemental Figure 6 ).
Interestingly, the suppressive capacity of the Tregs was increased in JSLE females compared to JSLE males, the opposite to what we found in healthy individuals ( Figure   5E -F). This appeared to be due to a loss of suppressive capacity in males with JSLE as opposed to an increase in females with JSLE. Furthermore, the differential sex-associated serum metabolite profile was also lost in patients with JSLE, including the altered VLDL composition in males vs females ( Figure   5G -H). Steroid treatment did not significantly influence metabolite profiles ( Figure 5I ). We next compared the metabolomic profile of healthy donors and JSLE patients separated by sex ( Figure 5J ). An increase in VLDL particles was found in SLE females whereas a decrease was observed in males. A subtle decrease in HDL particles was also identified in both JSLE males and females. The lipid composition of VLDL was also altered, characterised by differentially reduced phospholipid (PL), Triglyceride (TG) and free cholesterol (FC) content in male VLDL particles compared to females. Cholesterol (C) and cholesterol esters (CE) increased in all VLDL sizes in both male and female JSLE patients ( Figure 5K ).
Overall, these findings suggest that an alteration in hormone signalling in JSLE could contribute to changes in lipoprotein profile and composition, leading to a loss of differential male/female blood lipid taxonomy. Changes in lipid metabolism can influence immune cell function by influencing plasma membrane lipids, contributing to increased autoimmunity development and potentially increased cardiovascular risk in females. This hypothesis is summarised in Figure 6 .
Discussion
Here we describe a link between gender, lipid metabolism and Treg phenotype in healthy adolescent donors. Male Tregs had increased peripheral blood frequency, suppressive capacity and IL-4 production compared to Tregs from female donors; this was related to an increased Treg metabolic profile characterised by elevated GLUT-1 expression, plasma membrane lipid expression and plasma membrane fluidity in males compared to females. Healthy adolescent males and females had a distinctive serum metabolic signature including striking differences in VLDL serum lipoprotein particle distribution and lipid content. These signatures were positively correlated with an activated Treg phenotype in males and a resting Treg phenotype in females. In vitro culture with VLDL isolated from males and females was able to appropriately recapitulate the respective male or female Treg phenotype. Finally, sex differences in Treg and serum metabolomic profiles were lost in age matched patients with JSLE, a disease triggered during puberty, suggesting that pathogenesis could be related to dysregulated hormone signalling.
Our findings support previous observations of sexual dimorphism of Treg frequency across different age groups [1, 16] , despite evidence that FOXP3 is encoded on the Xchromsome [35] . Tregs from young healthy post-pubertal males were characterised by an increased peripheral blood frequency of Tregs with a Th-2 like phenotype (increased IL-4 production and GATA-3 expression). Th2-like Tregs have a greater viability than other subsets [36] and Treg-specific GATA3 knockout in mice results in spontaneous autoimmune disease development related to the regulation of FOXP3 by GATA3. These GATA3-deficient Tregs developed a pro-inflammatory Th17 phenotype [37, 38] .
Differences in T-cell plasma membrane glycosphingolipids and cholesterol (lipid raft components) are known to influence cell function by altering lipid raft structure and membrane fluidity [24, 25, 39, 40] . Cholesterol enrichment in CD4 T-cells results in increased proliferation and Th1 differentiation [41] . In the same study, cholesterol enrichment in Tregs had no effect on function. In support of this, we show that Tregs had no difference in cholesterol expression. However Treg GSL expression and GSL:cholesterol ratio was increased in male compared to female Tregs suggesting the plasma membrane was less ordered and more fluidic in males; this could have functional implications on cell signalling [24, 25] . Furthermore, GLUT-1, CD69 and GATA3 expression correlated positively with GSL levels in males but not in females. IL-4 increases GATA3 expression and Th2 differentiation in T-cells and the levels of GATA-3 are enhanced by concomitant TCR signalling [42] . Increased GSL levels in male Tregs may therefore play a role in driving the Th2 phenotype through increased TCR signalling.
Clinical measures of lipoproteins differ between healthy adult males and pre-menopausal females where males are at an increased risk of developing cardiovascular disease [10] [11] [12] . No studies have investigated in depth metabolomics regarding lipoprotein particle size and composition between adolescent healthy males and females. VLDL subsets and their lipid content, saturated and monounsaturated fatty acids were greatly increased in young males and HDL and polyunsaturated fats such as omega fatty acids, DHA and LA were increased in females. It has been previously reported that DHA is lower in males than females, thus supporting these findings [44] . This provides evidence that in adolescence, immediately after puberty, young males and females can already be segregated by metabolic signatures characteristic of their risk of developing cardiovascular disease in later life. It has been shown that the combined oral contraceptive pill (COCP) (combination of an estrogen (ethinylestradiol) and a progestogen (progestin)) increases circulating triglycerides and HDL cholesterol whereas the progestin only oral contraception has little effect on lipids [45] . In the same study the COCP also decreased polyunsaturated fats, together suggesting a complex role for hormones in altering lipid metabolism. Our data supports a role for estrogen in driving the HDL signature in females. The few studies examining lipids and GD however have contradictory observations. One study showed that transgender males develop increased TGs, total cholesterol and LDL-cholesterol as well as decreased HDL-cholesterol. Transgender females in the same study developed decreased total cholesterol and LDL-cholesterol [46] . Another report also identified a decrease in HDL levels in transgender males but found no difference in the lipid profile of transgender females [47] . Finally, a study in mice has shown that during high estrogen periods of the menstrual cycle there is an increased efflux of more efficient, atheroprotective HDL from liver hepatocytes. This is due to the increased co-regulated transcriptional activity of LXR's by ERα [48] . The hormonal influences we see here may be driven by the same mechanism. Hormone replacement therapy (HRT) could be a beneficial in female patients with JSLE to improve their lipid profile by increasing HDL. Previously, this view has been controversial since exogenous estrogen could induce disease symptoms and cause flares. Evidence surrounding this however remains elusive and further investigation is required [59] . . Further hormone studies will be required to underpin the exact signalling mechanisms that become defective in JSLE patients.
Relative to effector T-cell subsets, Tregs rely more heavily on lipids for their function via beta-oxidation [49] . Treg frequency is increased in individuals with dyslipidaemia; a positive correlation between Treg frequency and ApoB, LDL cholesterol and total cholesterol was identified [50] . In contrast, Treg frequency was increased in HDL-treated mice and a positive correlation between Treg frequency and HDL-cholesterol was reported in statin treated adults [51] . This study also showed that ABCG1 expression (implicated in cholesterol efflux) in human peripheral blood Tregs correlated with an increased Treg frequency; it was concluded that accumulation of cholesterol could alter T-cell homeostasis. Another study identified that depletion of Tregs in atherosclerosisprone, low-density lipoprotein receptor-deficient (Ldlr-/-) mice resulted in increased atherosclerosis associated with elevated plasma cholesterol and VLDL due to lack of clearance [52] . This demonstrates that Tregs may elicit the capability to alter lipoprotein metabolism. Differences in the Treg:lipoprotein axis in males and females could contribute to the differential Treg frequency and function observed here and could play a significant role in the development of atherosclerosis in females in the context of autoimmunity.
This study represents a rare opportunity to investigate Treg phenotype and serum metabolome in a young age matched JSLE cohort. Most studies have found a reduction in Treg frequency in SLE, with an improvement after treatment [56] , thus it was important that there was no significant difference in treatment between males and females in the cohort. Importantly we found no difference in the lipid metabolome of patients in this cohort with regards to steroid treatment despite evidence that steroid use can alter plasma lipid levels [57, 58] . Sex differences in Treg phenotype and function and serum metabolomics were lost in JSLE. Together this work adds complexity to the study of JSLE pathogenesis but highlights the importance of considering sex in autoimmune and metabolic research.
In summary, here we have identified a novel link between lipoprotein metabolism and Treg function in males and females. Males have a more pro-atherogenic metabolome and this influences Tregs to display a more suppresive phenotype compared to females; this could help to explain differences in autoimmune susceptibility. In JSLE, these sexassociated differences in Treg phenotype and serum metabolic profile are lost. This may be associated with altered hormone signalling although further investigation is required to dissect the precise mechanisms.
MATERIALS AND METHODS
Patients and control samples
Peripheral blood was collected from 35 
Flow cytometry
Surface Staining: 10 6 PBMCs were stained with fixable blue dead cell stain (ThermoFisher) or Zombie NIR™ Fixable Viability Kit (Biolegend) in PBS followed by washes and surface marker staining in Brilliant™ Stain Buffer (BD). The following antibodies were used: CD3-BV786 (Biolegend), CD8-BV421 (Biolegend), CD4-BUV395 (BD), CD25-PeDazzle594 (Biolegend), CD127-BV711 (Biolegend), CD27-AF700 (Biolegend) and CD27-PECy7 (Biolegend) ( Supplementary Figure 1 for gating). 1 million PBMCs per sample were stained for 30mins on ice followed by subsequent washes and fixation in 2% PFA. In some cases cells were also surface stained with GLUT-1-AF647 (abcam), CD69-BV510 (Biolegend) and PD-1-APC-Cy7 (Biolegend) antibodies using the same method.
Lipid staining: In some cases following surface staining, cells were subsequently stained with, cholera toxin B-FITC (CTB) binds to the glycosphingolipid GM1 [62] , (Sigma, 1:100 in PBS) for 30 mins on ice. Cells were fixed with 2% PFA (30mins at room temperature) followed by membrane cholesterol staining with filipin complex from (Sigma, 50μg/ml in PBS) [62] for 2hrs at room temperature.
For membrane order analysis, live cells were stained with 4 uM di-4-ANEPPDHQ (ANE) (ThermoFisher Scientific) for flow cytometry analysis as previously described [25] .
Intracellular staining: PBMCs were cultured for 4.5 hours in PMA (50ng/ml), ionomycin (250ng/ml) (Sigma) and GolgiPlug™ Protein Transport Inhibitor (BD Biosciences) followed by staining with Zombie NIR™ Fixable Viability Kit (Biolegend) (1/1000 in PBS).
Surface staining was carried out as above. Cells were then fixed and permeabilised in Fix/Perm buffer (Biolegend) (overnight at 4 o C) followed by intracellular cytokine staining with anti-human IL-10-APC (BD Biosciences), IL-4-PERCP Cy5.5 (Biolegend) and IFNγ-eFlour450 (ebioscience) in permeabilisation wash buffer (Biolegend) (45mins on ice).
Staining for FOXP3-PE (Biolegend), T-bet-APC (Biolegend) and GATA-3-AP488
(Biolegend) was carried out using the same method but without stimulation. 
Phospholipid detection
For phospholipid fluorescent staining, the HCS LipidTOX™ Phospholipidosis and Steatosis Detection Kit (thermofisher) was used as by the manufacturer's instruction.
Here the phospholipid stain was added to the culture with the VLDL stimulus and cells were cultured for 24 hours.
RNA extraction and analysis
Ex-vivo FACS sorted cell subsets or in vitro cultured CD4 + T-cell subsets at density of 0.5-1x10 6 were lysed and RNA was extracted and isolated using the PicoPure RNA Isolation Kit (ThermoFisher) according to manufacturer's instructions. cDNA was synthesised using qScript cDNA SuperMix (Quantabio). PerfeCTa® SYBR® Green FastMix (VWR) was added to cDNA for fluorescence quantification using a Stratagene Delta-or Delta-Delta-Ct (dCt or ddCt) algorithmic method of quantification was used to determine relative gene expression [64] .
Metabolomics
Nightingale metabolomics (https://nightingalehealth.com/), a service that measures 220 blood biomarkers [65] , was used to measure biomarkers in healthy control and JSLE patient serum (Supplemental Table 2 for list of biomarkers).
Statistical analysis
Analysis was performed in GraphPad Prism 7 software. Data was tested for normal distribution using Kolmogorov-Smirnov test and parametric or non-parametric tests were used accordingly. Unpaired or pared t-tests were used to compare ex-vivo patient group data or culture/pre-post matched sample data respectively. Linear regression was performed with a 95% confidence interval used to calculate significance (Pearson correlation). Multiple testing was also accounted for by use of FDR correction (Benjamini, Krieger and Yekutieli approach) of p-value thresholds. This was carried out on phenotyping and metabolomics data using Prism 7 software analysis of p-value stacks. 
Figure 6: Potential mechanism: How blood lipids influence immune cell function in healthy individuals and JSLE patients
Based on the findings described in this report we hypothesise that in healthy adolescence, (A) hormone signalling via estrogen and/or androgen receptors contribute to changes in blood lipids between males and females including the lipid content and size of VLDL. (B) Altered blood lipid taxonomy can influence immune cell function by changing the lipid content of the plasma membrane. (C) Increased VLDL in males drives increased cardiovascular risk in males; (D) Changes in immune cell activation between males and females can contribute to altered susceptibility to a range of diseases. (E) Potential defects in sex hormone signalling in patients with JSLE lead to a loss of differential male/female blood lipid
